Healthcare - Biotechnology - NASDAQ - US
$ 13.97
-7.61 %
$ 1.42 B
Market Cap
-2.56
P/E
Price Target
Average
265.07%
Revenue Forecast
Estimate
146.75%
EBIT
Estimate
--27.10%
Net Income
Estimate
24.24%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Intellia Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for NTLA of $51 , with forecasts ranging from a low of $18 to a high of $80 .
NTLA Lowest Price Target
Wall Street Target
18 USD
28.85%
NTLA Average Price Target
Wall Street Target
51 USD
265.07%
NTLA Highest Price Target
Wall Street Target
80 USD
472.66%
REVENUE FORECAST
Revenue Forecast Chart NTLA
EBIT FORECAST
EBIT Forecast Chart NTLA
NET INCOME FORECAST
Net Income Chart NTLA